Geneos Wealth Management’s Core & Main CNM Stock Holding History

Geneos Wealth Management’s Portfolio CNM Stock Details CNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19	Closed	-$1.15K	–	2625
2025 Q2	$1.15K	Buy	+19	New	+$1.02K	﹤0.01%	2946

Other funds holding CNM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geneos Wealth Management's CNM Position: Q3 2025 in Review

Geneos Wealth Management sold out of Core & Main (CNM) in Q3 2025, closing a stake of 19 shares — an estimated $1.15K sold.

Geneos Wealth Management first reported a position in CNM in Q2 2025 and held it in 1 quarter. The position peaked at $1.15K in Q2 2025. 429 funds tracked by Wall St. Rank hold CNM as of Q3 2025.

Geneos Wealth Management reported no remaining Core & Main position as of Q3 2025 after selling out during the quarter.
Geneos Wealth Management sold 19 Core & Main shares in Q3 2025, an estimated $1.15K.
Geneos Wealth Management first reported a position in Core & Main in Q2 2025 and held it in 1 quarter.
Geneos Wealth Management's Core & Main position peaked at $1.15K in Q2 2025.
429 funds tracked by Wall St. Rank held Core & Main as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.